https://www.selleckchem.com/pr....oducts/trastuzumab-d
86 (95% CI 0.79-0.9, 0.88 (95% CI 0.80-0.93), 7.05 (95% CI 4.20-11.84), 0.16 (95% CI 11-0.24), and 0.93, respectively. Taken together, these findings indicate that circulating microRNAs may serve as potential noninvasive biomarkers of endometriosis.PURPOSE To investigate the efficacy and safety of glaucoma medication in Japanese patients, network meta-analysis (NMA) of an intraocular pressure(IOP) reduction, adverse reaction rates and conjunctival congestion rates of major glaucoma drugs used in clinical practice in Jap
Like
Comment
Share
